401 related articles for article (PubMed ID: 15918296)
1. Nasal ECP patterns and specific immunotherapy in mite-allergic rhinitis patients.
Ferreira MB; Santos AS; Santos MC; Carlos ML; Barbosa MA; Carlos AG
Eur Ann Allergy Clin Immunol; 2005 Mar; 37(3):96-102. PubMed ID: 15918296
[TBL] [Abstract][Full Text] [Related]
2. Lower airway inflammation before and after house dust mite nasal challenge: an age and allergen exposure-related phenomenon.
Marcucci F; Passalacqua G; Canonica GW; Frati F; Salvatori S; Di cara G; Petrini I; Bernini M; Novembre E; Bernardini R; Incorvaia C; Sensi LG
Respir Med; 2007 Jul; 101(7):1600-8. PubMed ID: 17482451
[TBL] [Abstract][Full Text] [Related]
3. Three-year follow-up of clinical and inflammation parameters in children monosensitized to mites undergoing sub-lingual immunotherapy.
Marcucci F; Sensi L; Di Cara G; Salvatori S; Bernini M; Pecora S; Burastero SE
Pediatr Allergy Immunol; 2005 Sep; 16(6):519-26. PubMed ID: 16176400
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy in allergic rhinitis.
Palma-Carlos AG; Spinola-Santos A; Ferreira MB; Santos MC; Palma-Carlos ML
Allerg Immunol (Paris); 2001 Oct; 33(8):323-6. PubMed ID: 11763723
[TBL] [Abstract][Full Text] [Related]
5. Long-term efficacy of sublingual immunotherapy in patients with perennial rhinitis.
Tahamiler R; Saritzali G; Canakcioglu S
Laryngoscope; 2007 Jun; 117(6):965-9. PubMed ID: 17545861
[TBL] [Abstract][Full Text] [Related]
6. [Humoral mucosal immunity in allergic rhinitis].
Kramer MF; Jordan TR; Pfrogner E; Rasp G
Laryngorhinootologie; 2005 Jul; 84(7):503-10. PubMed ID: 16010632
[TBL] [Abstract][Full Text] [Related]
7. [The relationship between skin test results and serum eosinophilic cationic protein, nasal eosinophilia, and total IgE values in patients with allergic rhinitis].
Pinar E; Bolat F; Oncel S; Köseoğlu M; Yüksel H; Calli C
Kulak Burun Bogaz Ihtis Derg; 2005; 14(5-6):101-5. PubMed ID: 16340277
[TBL] [Abstract][Full Text] [Related]
8. [Serum eosinophil cationic protein (ECP) in patients with perennial rhinitis and atopic dermatitis, allergic to house dust mites].
Damps-Konstańska I; Gruchała-Niedoszytko M; Wilkowska A; Glén J; Konstański Z; Jassem E; Słomiński JM
Pol Merkur Lekarski; 2005 Dec; 19(114):765-8. PubMed ID: 16521419
[TBL] [Abstract][Full Text] [Related]
9. [The results of extra diagnostic methods in patients allergic to dust mites treated by specific immunotherapy].
Modrzyński M; Mazurek H; Zawisza E
Przegl Lek; 2005; 62(12):1337-42. PubMed ID: 16786743
[TBL] [Abstract][Full Text] [Related]
10. The effect of local nasal immunotherapy in allergic rhinitis: using strips of the allergen dermatophagoides pteronyssinus.
Tsai JJ; Liao EC; Tsai FH; Hsieh CC; Lee MF
J Asthma; 2009 Mar; 46(2):165-70. PubMed ID: 19253124
[TBL] [Abstract][Full Text] [Related]
11. Kinetics of eosinophil cationic protein release in mite-allergic rhinitis after specific nasal provocation.
Branco-Ferreira M; Palma-Carlos ML; Santos MC; Lopes AP; Palma-Carlos AG
Allerg Immunol (Paris); 1998 Apr; 30(4):104, 107-11. PubMed ID: 9631691
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-8 secretion in patients with allergic rhinitis after an allergen challenge: interleukin-8 is not the main chemotactic factor present in nasal lavages.
Gosset P; Tillie-Leblond I; Malaquin F; Durieu J; Wallaert B; Tonnel AB
Clin Exp Allergy; 1997 Apr; 27(4):379-88. PubMed ID: 9146930
[TBL] [Abstract][Full Text] [Related]
13. Effect of anti-immunoglobulin E on nasal inflammation in patients with seasonal allergic rhinoconjunctivitis.
Bez C; Schubert R; Kopp M; Ersfeld Y; Rosewich M; Kuehr J; Kamin W; Berg AV; Wahu U; Zielen S
Clin Exp Allergy; 2004 Jul; 34(7):1079-85. PubMed ID: 15248853
[TBL] [Abstract][Full Text] [Related]
14. Nasal inflammatory mediators and specific IgE production after nasal challenge with grass pollen in local allergic rhinitis.
Rondón C; Fernández J; López S; Campo P; Doña I; Torres MJ; Mayorga C; Blanca M
J Allergy Clin Immunol; 2009 Nov; 124(5):1005-11.e1. PubMed ID: 19796796
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor in allergen-induced nasal inflammation.
Choi GS; Park HJ; Hur GY; Choi SJ; Shin SY; Ye YM; Park HS
Clin Exp Allergy; 2009 May; 39(5):655-61. PubMed ID: 19236408
[TBL] [Abstract][Full Text] [Related]
16. Comparison of the long-term efficacy of subcutaneous and sublingual immunotherapies in perennial rhinitis.
Tahamiler R; Saritzali G; Canakcioglu S; Ozcora E; Dirican A
ORL J Otorhinolaryngol Relat Spec; 2008; 70(3):144-50. PubMed ID: 18391573
[TBL] [Abstract][Full Text] [Related]
17. [Analysis of the efficacy of specific immunotherapy with house-dust mite extracts in adults with allergic rhinitis and/or asthma].
Polzehl D; Keck T; Riechelmann H
Laryngorhinootologie; 2003 Apr; 82(4):272-80. PubMed ID: 12717603
[TBL] [Abstract][Full Text] [Related]
18. The effects of grass pollen allergoid immunotherapy on clinical and immunological parameters in children with allergic rhinitis.
Keskin O; Tuncer A; Adalioglu G; Sekerel BE; Saçkesen C; Kalayci O
Pediatr Allergy Immunol; 2006 Sep; 17(6):396-407. PubMed ID: 16925684
[TBL] [Abstract][Full Text] [Related]
19. Comparison between the use of adsorbed and aqueous immunotherapy material in Dermatophagoides pteronyssinus sensitive asthmatic children.
Altintaş D; Akmanlar N; Güneşer S; Burgut R; Yilmaz M; Buğdayci R; Aksungur P
Allergol Immunopathol (Madr); 1999; 27(6):309-17. PubMed ID: 10611556
[TBL] [Abstract][Full Text] [Related]
20. Effect of allergen-specific immunotherapy on plasma level of platelet factor 4 (PF-4) and beta-thromboglobulin (beta-TG), platelet activation markers in patients with house dust mite allergy.
Kasperska-Zajac A; Brzoza Z; Rogala B
Vaccine; 2007 May; 25(18):3595-8. PubMed ID: 17291641
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]